Prevention of organ rejection in renal and liver transplantation with extended release tacrolimus
Michael E Reschen, Christopher A O’Callaghan Henry Wellcome Building, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom Abstract: Tacrolimus is the key immunosuppressant used to prevent allograft rejection in kidney and liver transplant recipients. Despite the...
Main Authors: | Reschen ME, O'Callaghan CA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Transplant Research and Risk Management |
Online Access: | http://www.dovepress.com/prevention-of-organ-rejection-in-renal-and-liver-transplantation-with--peer-reviewed-article-TRRM |
Similar Items
-
Role of tacrolimus prolonged release in the prevention of allograft rejection
by: Peter Abrams, et al.
Published: (2010-08-01) -
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
by: P Dalal, et al.
Published: (2010-08-01) -
Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
by: Gerold Thölking, et al.
Published: (2021-08-01) -
Tacrolimus in preventing transplant rejection in Chinese patients – optimizing use
by: Li CJ, et al.
Published: (2015-01-01) -
Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
by: Johannes von Einsiedel, et al.
Published: (2020-06-01)